Therapeutic monitoring of TNF inhibitors for rheumatoid arthritis: evidence required following NICE's recommendations
- PMID: 32914047
- PMCID: PMC7474855
- DOI: 10.1093/rap/rkaa023
Therapeutic monitoring of TNF inhibitors for rheumatoid arthritis: evidence required following NICE's recommendations
Figures
References
-
- Vincent F, Morand E, Murphy K. et al. Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective. Ann Rheum Dis 2013;72:165–78. - PubMed
-
- EULAR Study Group on Therapeutic Drug Monitoring of Biologics [Internet]. Kilchberg: European League Against Rheumatism; 2018. https://www.eular.org/myUploadData/files/publication_document_therapeuti....
-
- National Institute for Health and Care Excellence. Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis. Diagnostics guidance: DG36. Manchester: National Institute for Health and Care Excellence, 2019.
-
- National Institute for Health and Care Excellence. Diagnostics assessment programme manual. Manchester: National Institute for Health and Care Excellence, 2011. - PubMed
-
- Drummond M, Sculpher M, Claxton K, Stoddart G, Torrance G.. Methods for the economic evaluation of health care programmes. 4 edn Oxford: Oxford University Press, 2015.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources